Role of intracellular redox status in apoptosis induction of human T-cell leukemia virus type I-infected lymphocytes by 13-cis-retinoic acid.

We have shown that cell cycle progression of human T-cell leukemia virus type I (HTLV-I)-transformed T-cell lines was inhibited by 13-cis-retinoic acid (13cRA). In the present study, we report that 13cRA inhibited proliferation and induced cell death of peripheral blood mononuclear cells obtained from four patients with acute adult T-cell leukemia but not of mitogen- or interleukin 2-activated peripheral blood mononuclear cells from HTLV-I-negative healthy donors. Because HTLV-I-infected lymphocytes are susceptible to oxidative stress, we examined the role of the intracellular redox state in 13cRA-induced cell death using a HTLV-I-positive T-cell line, ATL2, as a model. 13cRA induced apoptosis in ATL2 cells within 48 h in a dose-dependent manner. The ability of 13cRA to induce apoptosis was more potent than that of all-trans-retinoic acid. Apoptosis induction by 13cRA was significantly enhanced by buthionine sulfoximine (BSO), which decreased the levels of intracellular reduced glutathione, although 13cRA by itself did not alter them, suggesting that intracellular reduced glutathione may modulate 13cRA-induced apoptosis. In addition, flow cytometric analysis revealed that 13cRA increased intracellular peroxides in 24 h and that the addition of BSO further enhanced them. Although N-acetylcysteine had only a marginal effect, pretreatment with catalase markedly inhibited 13cRA-induced apoptosis. These results suggest that peroxide generation, ie., oxidative stress, may play a crucial role in the induction of apoptosis by 13cRA and further demonstrate that combined treatment with 13cRA and BSO induces apoptosis of HTLV-I-positive lymphocytes even more potently.

[1]  H. Sies,et al.  Oxidative stress: oxidants and antioxidants , 1997, Experimental physiology.

[2]  K. Mehta,et al.  Possible involvement of Bcl-2 pathway in retinoid X receptor alpha-induced apoptosis of HL-60 cells. , 1997, Biochemical and biophysical research communications.

[3]  Y. Hiraku,et al.  Oxidative DNA damage and apoptosis induced by benzene metabolites. , 1996, Cancer research.

[4]  J. Ernst,et al.  Asbestos induces apoptosis of human and rabbit pleural mesothelial cells via reactive oxygen species. , 1996, The Journal of clinical investigation.

[5]  P. Chambon,et al.  RXRalpha‐null F9 embryonal carcinoma cells are resistant to the differentiation, anti‐proliferative and apoptotic effects of retinoids. , 1996, The EMBO journal.

[6]  John Calvin Reed,et al.  Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells. , 1996, Cancer research.

[7]  M. Tomonaga,et al.  Relation of oxidative stress and glutathione synthesis to CD95(Fas/APO-1)-mediated apoptosis of adult T cell leukemia cells. , 1996, Journal of immunology.

[8]  J. Yodoi,et al.  Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): protective effect of human thioredoxin against CDDP-induced cytotoxicity. , 1996, The Journal of clinical investigation.

[9]  T. McDonnell,et al.  Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX. , 1996, Journal of immunology.

[10]  I. Kanazawa,et al.  Bcl-2 inhibits retinoic acid-induced apoptosis during the neural differentiation of embryonal stem cells , 1996, The Journal of cell biology.

[11]  S. Castro-Obregón,et al.  Role of retinoic acid and oxidative stress in embryonic stem cell death and neuronal differentiation , 1996, FEBS letters.

[12]  R. Ozols,et al.  Time-dependent pharmacodynamic models in cancer chemotherapy: population pharmacodynamic model for glutathione depletion following modulation by buthionine sulfoximine (BSO) in a Phase I trial of melphalan and BSO. , 1995, Cancer research.

[13]  V. Ferrans,et al.  Requirement for Generation of H2O2 for Platelet-Derived Growth Factor Signal Transduction , 1995, Science.

[14]  W. Hong,et al.  Induction of apoptosis by retinoids in human cervical-carcinoma cell-lines. , 1995, International journal of oncology.

[15]  G. Shipley,et al.  Activation of retinoid X receptors induces apoptosis in HL-60 cell lines , 1995, Molecular and cellular biology.

[16]  T. Buttke,et al.  Redox regulation of programmed cell death in lymphocytes. , 1995, Free radical research.

[17]  M. Dawson,et al.  Evidence for the Involvement of Retinoic Acid Receptor RAR-dependent Signaling Pathway in the Induction of Tissue Transglutaminase and Apoptosis by Retinoids (*) , 1995, The Journal of Biological Chemistry.

[18]  S. Nagata,et al.  The Fas death factor , 1995, Science.

[19]  Y. Yamaoka,et al.  Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide. , 1994, Immunology letters.

[20]  M. Vora,et al.  Retinoids upregulate phagocytosis by human dermal microvascular endothelial cells , 1994, Journal of cellular physiology.

[21]  V. Giguère Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. , 1994, Endocrine reviews.

[22]  Z. Oltvai,et al.  Bcl-2 functions in an antioxidant pathway to prevent apoptosis , 1993, Cell.

[23]  S. Korsmeyer,et al.  Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death , 1993, Cell.

[24]  T. Honjo,et al.  Induced expression of PD‐1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. , 1992, The EMBO journal.

[25]  M. Roederer,et al.  N-acetylcysteine: a new approach to anti-HIV therapy. , 1992, AIDS research and human retroviruses.

[26]  H. Nakamura,et al.  Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells. , 1991, Journal of immunology.

[27]  P. Moldéus,et al.  The metabolism of N-acetylcysteine by human endothelial cells. , 1991, Biochemical pharmacology.

[28]  I Nicoletti,et al.  A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. , 1991, Journal of immunological methods.

[29]  M. Roederer,et al.  Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Mckeown,et al.  Relationship between the product of the Drosophila ultraspiracle locus and the vertebrate retinoid X receptor , 1990, Nature.

[31]  R. Evans,et al.  Nuclear receptor that identifies a novel retinoic acid response pathway , 1990, Nature.

[32]  G. Wong,et al.  Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor , 1989, Cell.

[33]  J. Wood,et al.  The stereospecific suicide inhibition of human melanoma thioredoxin reductase by 13-cis-retinoic acid. , 1989, Biochemical and biophysical research communications.

[34]  K. Arai,et al.  ATL‐derived factor (ADF), an IL‐2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol‐reduction in the IL‐2 receptor induction. , 1989, The EMBO journal.

[35]  K. Asada,et al.  [Metabolism and function of glutathione in plants]. , 1988, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[36]  Pierre Chambon,et al.  A human retinoic acid receptor which belongs to the family of nuclear receptors , 1987, Nature.

[37]  V. Giguère,et al.  Identification of a receptor for the morphogen retinoic acid , 1987, Nature.

[38]  J. Wood,et al.  The role of thioredoxin reductase in the reduction of free radicals at the surface of the epidermis. , 1986, Biochemical and biophysical research communications.

[39]  M. Winker,et al.  Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion. , 1985, Biochemical pharmacology.

[40]  S. Collins,et al.  Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[41]  S. Strickland,et al.  The induction of differentiation in teratocarcinoma stem cells by retinoic acid , 1978, Cell.

[42]  John Calvin Reed,et al.  Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2. , 1995, Blood.

[43]  H. Nakamura,et al.  Cell cycle inhibition of HTLV-I transformed T cell lines by retinoic acid: the possible therapeutic use of thioredoxin reductase inhibitors. , 1995, Oncology research.

[44]  T. Buttke,et al.  Oxidative stress as a mediator of apoptosis. , 1994, Immunology today.

[45]  P Chambon,et al.  Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[46]  J. Yodoi,et al.  Diseases associated with HTLV-I: virus, IL-2 receptor dysregulation and redox regulation. , 1992, Immunology today.

[47]  H. Nakamura,et al.  Lymphocyte transformation and thiol compounds; the role of ADF/thioredoxin as an endogenous reducing agent. , 1992, Molecular Immunology.

[48]  M. Sporn,et al.  Cellular biology and biochem-istry of the retinoids , 1984 .